Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Will vitamin D supplementation ameliorate diseases characterized by chronic inflammation and fatigue?

Hoeck AD, Pall ML.

Med Hypotheses. 2011 Feb;76(2):208-13. doi: 10.1016/j.mehy.2010.09.032.

PMID:
20980105
2.

Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.

Farmer PK, He X, Schmitz ML, Rubin J, Nanes MS.

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E213-20.

3.
4.

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.

Tan X, Wen X, Liu Y.

J Am Soc Nephrol. 2008 Sep;19(9):1741-52. doi: 10.1681/ASN.2007060666.

5.

Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway.

Kim MK, Chung SW, Kim DH, Kim JM, Lee EK, Kim JY, Ha YM, Kim YH, No JK, Chung HS, Park KY, Rhee SH, Choi JS, Yu BP, Yokozawa T, Kim YJ, Chung HY.

Exp Gerontol. 2010 Jun;45(6):419-26. doi: 10.1016/j.exger.2010.03.005.

PMID:
20211236
6.

Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling.

Yao H, Yang SR, Kode A, Rajendrasozhan S, Caito S, Adenuga D, Henry R, Edirisinghe I, Rahman I.

Biochem Soc Trans. 2007 Nov;35(Pt 5):1151-5. Review.

PMID:
17956299
8.

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

Cantorna MT, Zhu Y, Froicu M, Wittke A.

Am J Clin Nutr. 2004 Dec;80(6 Suppl):1717S-20S. Review.

9.

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P.

J Clin Invest. 1998 Jan 1;101(1):252-62.

10.

Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches.

Rahman I, MacNee W.

Free Radic Biol Med. 2000 May 1;28(9):1405-20. Review.

PMID:
10924859
11.

Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF, Pasparakis M.

Nature. 2007 Mar 29;446(7135):557-61.

12.

Vitamin D resistance.

Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G.

Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):627-45. Review.

PMID:
17161336
13.

Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus.

Babar M, Abdel-Latif MM, Ravi N, Murphy A, Byrne PJ, Kelleher D, Reynolds JV.

Dis Esophagus. 2010 Apr;23(3):271-6. doi: 10.1111/j.1442-2050.2009.01027.x.

PMID:
19930402
14.

Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde.

Kim DH, Kim CH, Kim MS, Kim JY, Jung KJ, Chung JH, An WG, Lee JW, Yu BP, Chung HY.

Biogerontology. 2007 Oct;8(5):545-54.

PMID:
17486422
15.

Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB.

Carrier JC, Aghdassi E, Jeejeebhoy K, Allard JP.

Int J Colorectal Dis. 2006 May;21(4):381-7.

PMID:
16133010
16.

Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.

Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA, Haussler MR.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V2-10. doi: 10.1359/jbmr.07s216.

17.

IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.

Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G, Saitta A, Cucinotta D, Ceccarelli S, Ferlito M, Tringali M, Minutoli L, Caputi AP, Squadrito F.

Cardiovasc Res. 2000 Aug 18;47(3):515-28.

PMID:
10963724
18.

Vitamin D physiology.

Lips P.

Prog Biophys Mol Biol. 2006 Sep;92(1):4-8. Review.

PMID:
16563471
19.
Items per page

Supplemental Content

Support Center